A5004271710- Chronic Lymphocytic Leukemia Research
- Pharmaceutical Practices and Patient Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Platelet Disorders and Treatments
- Asian Studies and History
- Historical Economic and Social Studies
- Cultural History and Identity Formation
- Patient Safety and Medication Errors
- Blood groups and transfusion
- Electronic Health Records Systems
- Japanese History and Culture
- Diabetes Treatment and Management
- Animal Disease Management and Epidemiology
- Cancer Treatment and Pharmacology
- Viral Infections and Vectors
- Zoonotic diseases and public health
- Chinese history and philosophy
- Multiple Myeloma Research and Treatments
- Immunodeficiency and Autoimmune Disorders
Monash University
2023-2024
St. Luke's International University
2024
Incident reports of medication errors are valuable learning resources for improving patient safety. However, pertinent information is often contained within unstructured free text, which prevents automated analysis and limits the usefulness these data. Natural language processing can structure this text automatically retrieve relevant past incidents materials, but to be able do so requires a large, fully annotated validated corpus incident reports. We present 58,658 machine-annotated that...
Abstract A hallmark of the media publicity surrounding COVID-19 has been message that land change causes zoonotic diseases to spill over from wild animals humans. The secondary peer-reviewed literature sends a similar message. However, as indicated in primary literature, complexity interacting variables involved disease spillover makes it unlikely for such claim be universally applicable. and mainstream also differ markedly their lack nuance messaging about relationship between risk. We...
Multiple myeloma is a haematological malignancy typically characterised by neoplastic plasma cell infiltration of the bone marrow. Treatment for multiple consists multi-line chemotherapy with or without autologous stem transplantation and has been rapidly evolving in recent years. However, clinical trials are unable to provide patients clinicians long-term prognostic information nor policymakers full body evidence needed perform economic evaluation new therapies make reimbursement decisions....